Goce Taleski Selected Research

Alzheimer Disease (Alzheimer's Disease)

1/2023	Methyl donor supplementation reduces phospho-Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy.
1/2018	Methylenetetrahydrofolate Reductase Deficiency Deregulates Regional Brain Amyloid-β Protein Precursor Expression and Phosphorylation Levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Goce Taleski Research Topics

Disease

2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2018
2	Neoplasms (Cancer) 01/2022 - 01/2021
2	Methylenetetrahydrofolate reductase deficiency 01/2018 - 01/2014
1	Cognitive Dysfunction 01/2023
1	Dementia (Dementias) 01/2023
1	Tauopathies 01/2023
1	Frontotemporal Dementia (Semantic Dementia) 01/2023
1	Neuroblastoma 01/2021

Drug/Important Bio-Agent (IBA)

3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023 - 01/2014
3	HomocysteineIBA 01/2023 - 01/2014
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2023 - 01/2014
2	CarbonIBA 01/2023 - 01/2021
1	Betaine (C.B.B.)FDA Link 01/2023
1	Choline (Choline Chloride)IBA 01/2023
1	5-methyltetrahydrofolateIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2022
1	EpitopesIBA 01/2022
1	HoloenzymesIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	CystathionineIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2014
1	EnzymesIBA 01/2014